Advertisement

Topics

Latest "Infobahn International, Inc" News Stories

12:45 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Infobahn International, Inc" found in our extensive news archives from over 250 global news sources.

More Information about Infobahn International, Inc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Infobahn International, Inc for you to read. Along with our medical data and news we also list Infobahn International, Inc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Infobahn International, Inc Companies for you to search.

Showing "Infobahn International" News Articles 1–25 of 5,800+

Tuesday 25th September 2018

Imfinzi is the First Immunotherapy to Demonstrate Significant Overall Survival Benefit in Unresectable, Stage III Lung Cancer

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of IMFINZI® (durvalumab) during the Presidential Symposium of the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Toronto, Canada. R...


PMI: Taking Bold Action for Global Change: a Conversation on Tobacco Today and Transformation for Tomorrow

During the 2018 Concordia Annual Summit, taking place in September 24 & 25 in New York, André Calantzopoulos, CEO of Philip Morris International, delivered a speech highlighting the need to have a dialogue between the industry, leaders, policy-makers, scientists, medical, and public health professionals in order to provide the 1.1 billion people who s...

Poziotinib maintains high response rate against harmful lung cancer mutation

Early results from a phase 2 clinical trial, reported today at the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer, show 24 of 44 patients (55 percent) with exon 20 mutations in the epidermal...


Klick Health’s Incubated Startup, Circulation, Announces Successful Exit

Agency’s commercialization practice thriving as it continues to introducenew healthcare innovation and modern business models Klick Health’s growing commercialization partner portfolio is proud of the successful exit of Circulation, one of Klick’s first incubation initiatives. Circulation has

Hypnobabies® is Revolutionizing Natural Childbirth, Offering Mothers a Drug-Free Alternative ...

STANTON, Calif., Sept. 25, 2018 /PRNewswire/ -- Hypnobabies, an international leader in childbirth hypnosis education, is revolutionizing natural childbirth by creating a more relaxing, comfortable Read more...

Baxter Recognized as One of Working Mother’s 2018 ‘100 Best Companies’

Baxter International Inc. (NYSE: BAX), a leading global medical products company, today announced that it has been named to Working Mother magazine’s 2018 ‘100 Best Companies’ list. Baxter was honored for providing progressive employee programs and benefits that support career advancement, workplace flexibility,

Tandem Diabetes Care Increases 2018 Sales Guidance and Provides Estimated Third Quarter Sales Results

Continued Domestic Demand and International Launch of the t:slim X2 Insulin Pump Drive Growth Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that it has increased its 2018 sales guidance to $150 million...

Keynote speakers announced for Hyperspectral Imaging Conference

Keynote speakers have been announced for HSI 2018, the 7th international conference on Hyperspectral Imaging & Applications, co-located with Photonex Europe taking place on 10th & 11th October at the Ricoh Arena, Coventry, UK. HSI 2018 brings together academic and industrial users to share their knowledge of innovations in hyperspectral imaging cameras, technology and applications....

AstraZeneca, MedImmune: Imfinzi Significantly Improved OS In PACIFIC Trial

British drug major AstraZeneca (AZN.L, AZN) and MedImmune Inc. (MEDI), the company's global biologics research and development arm, said Tuesday that they presented data on overall survival or OS in the Phase III PACIFIC trial of Imfinzi, during the Presidential Symposium of the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Toron...

Trump Calls For UN Countries To Pledge To Fight Illicit Drug Problem, But Focus On Opioids Causes Some To Balk

The pledge called on countries to develop national action plans to reduce demand for illicit drugs through education, expand treatment efforts, strengthen international cooperation on justice, law enforcement and health, and cut off the supply by stopping production.

Same-Day Dental Crowns in Morristown, NJ Crafted by Drs. Hal and Adam Kimowitz at Denville Dentist

Dentists Drs. Hal and Adam Kimowitz of Denville Dentist are now accepting new patients with or without a referral to restore their dental implants with customized same-day dental crowns in Morristown, NJ. Thanks to the practices high-end CEREC® equipment and corresponding technology, the doctors can create dental crowns in one day. Morristown, NJ (PRWEB) September 25, 2018 The dental team of...

LabVantage Solutions Names John Heiser Chief Executive Officer

—New CEO Brings Deep and Diverse Skill Set and Record of Strong Leadership in Building Global Technology and Life Sciences Businesses— —LabVantage Is a Leading Global Provider of Laboratory Informatics Services Offering Purpose-Built Solutions that Bundle Its LIMS Software with Features Tailored to Industry-Specific Needs— LabVa...

Promising phase 1/2 results for entrectinib against ROS1 non-small cell lung cancer

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer (NSCLC) presented on the press program of the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung...

Applied DNA Expands Cannabis Tagging Portfolio to Address Large Growers

Applied DNA Sciences Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”) announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution. On the heels of its successful showing of its first Cannabis Tagging System (CTS) in July in...

HOLLOWAY AMERICA to Demonstrate Innovations in Smart Tank Technology at 2018 ISPE Boston Area Product Show

The pressure vessel fabrication company will showcase its flagship smart tank, The intelliVessel™, as well as its other innovations in pharmaceutical vessels and tanks. BOSTON (PRWEB) September 25, 2018 Springfield, Mo.-based pressure vessel fabrication company HOLLOWAY AMERICA recently announced it will attend and exhibit at the ISPE Boston Area Chapter Product Show at the Gillette Stadium in ...

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines Keele, Darlington and London, 25 September 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, today announced a collaboration with the Centre for Process Innovation (CPI), a UK-based techno...

Precision For Medicine expandiert nach Zentral- und Südosteuropa; mehr als 300 Mitarbeiter im ...

DURCH DIE ÜBERNAHME VON ARGINT INTERNATIONAL ERREICHEN DIE DIENSTLEISTUNGEN VON PRECISION NUN GANZ EUROPA, MIT STARKER PRÄSENZ IN UNGARN, POLEN, RUMÄNIEN, DER SLOWAKEI UND IN Read more...

Spoločnosť Precision For Medicine expanduje do strednej a juhovýchodnej Európy; počet ...

AKVIZÍCIA SPOLOČNOSTI ARGINT INTERNATIONAL POMÁHA ETABLOVAŤ SLUŽBY FIRMY PRECISION V EURÓPE SO ZASTÚPENÍM V MAĎARSKU, POĽSKU, RUMUNSKU, NA SLOVENSKU A V SRBSKU BETHESDA, Maryland, 25. Read more...

Precision for Medicine se expande a Europa central y sudoriental, y supera los 300 empleados ...

LA ADQUISICIÓN DE ARGINT INTERNATIONAL ASIENTA LOS SERVICIOS DE PRECISION FOR MEDICINE EN TODA EUROPA, CON UNA SÓLIDA PRESENCIA EN HUNGRÍA, POLONIA, RUMANÍA, ESLOVAQUIA Y Read more...

Компания Precision For Medicine расширяет своё присутствие в ...

ПРИОБРЕТЕНИЕ ARGINT INTERNATIONAL ОБЕСПЕЧИВАЕТ КОМПАНИИ МОЩНОЕ ПРИСУТСТВИЕ В ВЕНГРИИ, ПОЛЬШЕ, РУМЫНИИ, СЛОВАКИИ И СЕРБИИ БЕТЕСДА (BETHESDA), Мэриленд, 25 сентября 2018 г. /PRNewswire/ -- Компания Precision Read more...

Precision For Medicine poszerza działalność w Europie Środkowej i Południowowschodniej, ...

NABYCIE ARGINT INTERNATIONAL OBEJMUJE USŁUGAMI PRECISION EUROPĘ Z DUŻYMI OŚRODKAMI NA WĘGRZECH, W POLSCE, RUMUNII, SŁOWACJI I SERBII BETHESDA, Maryland, 25 września 2018 r. /PRNewswire/ Read more...

Precision For Medicine élargit sa présence en Europe centrale et du Sud-Est ; elle compte ...

L'ACQUISITION D'ARGINT INTERNATIONAL INSTALLE LES SERVICES DE PRECISION EN EUROPE AVEC UNE SOLIDE PRÉSENCE EN HONGRIE, EN POLOGNE, EN ROUMANIE, EN SLOVAQUIE ET EN SERBIE Read more...

Společnost Precision For Medicine expanduje do střední a jihovýchodní Evropy; překračuje ...

AKVIZICE SPOLEČNOSTI ARGINT INTERNATIONAL ETABLUJE SLUŽBY SPOLEČNOSTI PRECISION V EVROPĚ SE SILNOU PŮSOBNOSTÍ V MAĎARSKU, POLSKU, RUMUNSKU, SLOVENSKU A SRBSKU BETHESDA, Maryland, 25. září 2018 Read more...

Chemesis International Inc.: Einstieg in den -4-

DJ Chemesis International Inc.: Einstieg in den Cannabis Getränkesektor perfekt - Aktie auf der Überholspur - Kurse von 2 Euro zum Greifen nahe! Dow Jones hat von EQS/DGAP eine Zahlung für die Ver...

Chemesis International Inc.: Einstieg in den -3-

DJ Chemesis International Inc.: Einstieg in den Cannabis Getränkesektor perfekt - Aktie auf der Überholspur - Kurse von 2 Euro zum Greifen nahe! Dow Jones hat von EQS/DGAP eine Zahlung für die Ver...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks